We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Camurus AB (CAMX) NPV

Sell:484.40 SEK Buy:485.60 SEK Change: 11.40 SEK (2.41%)
Market closed |  Prices as at close on 19 April 2024 | Switch to live prices |
Sell:484.40 SEK
Buy:485.60 SEK
Change: 11.40 SEK (2.41%)
Deal now Deal for just £11.95 per trade in a Stocks and Shares ISA, Lifetime ISA , SIPP or Fund and Share Account
Deal now
Market closed |  Prices as at close on 19 April 2024 | Switch to live prices |
Sell:484.40 SEK
Buy:485.60 SEK
Change: 11.40 SEK (2.41%)
Market closed |  Prices as at close on 19 April 2024 | Switch to live prices |
Deal now Deal for just £11.95 per trade in a Stocks and Shares ISA, Lifetime ISA , SIPP or Fund and Share Account
Deal now
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Camurus AB is a Sweden-based research and development based pharmaceutical and biotechnology company with a focus on the development and marketing of specialty medicines, providing patients suffering from severe and chronic disease, such as opioid dependence, pain, cancer, and endocrine diseases. The Company has a diversified research portfolio, which includes products in clinical trials. The Company’s products are based on FluidCrystal formulation technology. FluidCrystal is Company's patent-protected technology platform. Camurus AB is the parent company of the Group, which comprises of legal entities, namely: Camurus Inc, Cubosome Inc, Development AB, Camurus GmbH, Camurus Ltd, Camurus Oy, Camurus AS, Camurus SAS, Camurus Pty Ltd, Camurus S.L, Camurus ApS, Camurus BV and Camurus Austria GmbH.

Contact details

Address:
Ideongatan 1A
LUND
223 62
Sweden
Telephone:
+46 (46) 2865730
Website:
https://www.camurus.com/

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
CAMX
ISIN:
SE0007692850
Market cap:
27.29 billion SEK
Shares in issue:
55.62 million
Sector:
Pharmaceuticals
Exchange:
Stockholm Stock Exchange
Country:
Sweden
Currency:
Swedish Krona
Indices:
n/a

Key personnel

  • Fredrik Tiberg
    President, Chief Executive Officer, Chief Scientific Officer, Director
  • Jon Alonso
    Chief Financial Officer
  • Markus Johnsson
    Senior Vice President R & D
  • Torsten Malmstroem
    Chief Technical Officer
  • Annette Mattsson
    Vice President - Regulatory Affairs
  • Agneta Svedberg
    Vice President, Clinical Development and Pharmacovigilance
  • Fredrik Joabsson
    Chief Business Development Officer
  • Richard Jameson
    Chief Commercial Officer
  • Maria Lundqvist
    Global Head of Human Resources

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.
Deal now Deal for just £11.95 per trade in a Stocks and Shares ISA, Lifetime ISA , SIPP or Fund and Share Account
Deal now

Options

Share

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.